Ruth Demmer-Steingruber
study nurse
Medizinische Onkologie und Hämatologie · Dept. I
A Phase III Trial Evaluating the Role of Exemestane Plus GnRH Analogue as Adjuvant Therapy for Premenopausal Women with Endocrine Responsive Breast Cancer
Sep 3, 2009
Clinical Studies - Sep 3, 2009 - Dec 31, 2099
Ongoing
Project leader: Huober Jens
Members: Demmer-Steingruber Ruth, Quinter Janine
Eine Substudie zur TEXT-Studie zur Untersuchung der Knochendichte und Analyse von Knochenmarkern und Wachstumsfaktoren Substudie zur Studie zu Tamoxifen und Exemestan (IBCSG 25-02 / BIG 3-02 TEXT)
Sep 3, 2009
Clinical Studies - Sep 3, 2009 - Dec 31, 2099
Ongoing
Project leader: Huober Jens
Members: Demmer-Steingruber Ruth, Quinter Janine
Prospective evaluation of the predictive value of PET in patients with diffuse large B-cell-lymphoma under R-CHOP-14. A multicenter study
Jan 28, 2008Das diffuse grosszellige B-Zell-Lymphom gehört zu den aggressiven Non-Hodgkin Lymphomen und ist der am häufigsten auftretende Lymphomsubtyp. Die international anerkannte Standardtherapie für die Mehrzahl der Patienten ist die sogenannte R-CHOP Immun...
Clinical Studies - Jan 28, 2008 - Sep 28, 2011
Automatically Closed
Project leader: Driessen Christoph
Members: Demmer-Steingruber Ruth
Ibritumomab tiuxetan and high-dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy. A multicenter phase I trial
Oct 25, 2006Identification of the maximum tolerated dose (MTD) of melphalan in combination with ibritumomab tiuxetan in patients ≥ 65 years with relapsed or chemotherapy resistant CD20+ lymphoma. Evaluation of feasibility and safety of ibritumomab tiuxetan...
Clinical Studies - Oct 25, 2006 - Oct 25, 2010
Completed
Project leader: Hitz Felicitas
Members: Demmer-Steingruber Ruth